CIHR Internal Assessment - Report for the 2011 International Review

[ Table of Contents ]


CIHR's first 10 years were highly creative, characterized by a variety of novel approaches and funding mechanisms and sustained by unprecedented budgetary growth. The challenge ahead will be to sustain the organization's dynamism and creativity in the period of budgetary restraint that is likely to stem from the current economic downturn.

In its Roadmap for 2009–2014, CIHR has applied learning from its first 10 years and kept the spirit of imagination and innovation while attempting to reduce some of the complexity that had arisen from its rapid growth. It will focus its research priorities, simplify its program offerings, reform its peer review system, reduce the number of small initiatives, and emphasize ambitious, multi-institute and partnered initiatives. These ambitious new research initiatives will require closer collaboration among institutes, increased buy-in from public and private partners and larger involvement of health research users. These actions, in turn, will require increased openness (particularly towards the provinces) and greater nimbleness on the part of CIHR.

CIHR will continue to insist on scientific excellence and potential for impact in all the research that it funds. It will support the training and career development of the next generation of researchers. Through increased interaction with health professionals, health system managers and policy makers, CIHR will prove the value that health research holds in prevention, diagnosis and treatment, in sustaining and improving a high-quality and affordable health care system, and in developing public policy informed by evidence. It will assist in the transfer of discoveries with commercial potential from invention to industrial development. Through improved reporting on the outcomes and impacts of its funding, CIHR will convince Canadians of the economic and social value of continuing investment in health research. The guidance of the second International Review Panel will be vital to CIHR's success over the next challenging but exciting five years.

List of Acronyms and Abbreviations

List of Institutes

IAPH Institute of Aboriginal Peoples' Health
IA Institute of Aging
ICR Institute of Cancer Research
ICRH Institute of Circulatory and Respiratory Health
IGH Institute of Gender and Health
IG Institute of Genetics
IHSPR Institute of Health Services and Policy Research
IHDCYH Institute of Human Development, Child and Youth Health
III Institute of Infection and Immunity
IMHA Institute of Musculoskeletal Health and Arthritis
INMHA Institute of Neurosciences, Mental Health and Addiction
INMD Institute of Nutrition, Metabolism and Diabetes
IPPH Institute of Population and Public Health

Report specific

CECR Centres of Excellence for Commercialization of Research
CERC Canada Excellence Research Chairs
CHSRF Canadian Health Services Research Foundation
CIHR Canadian Institutes of Health Research
CFI Canada Foundation for Innovation
CRC Canada Research Chairs
FRSQ Fonds de la recherche en santé du Québec
GC Governing Council
GDP Gross Domestic Product
IAB Institute Advisory Board
IC Industry Canada
IDRC International Development Research Centre
IRP International Review Panel
KT knowledge translation
MOU memorandum of understanding
MRC Medical Research Council of Canada
NCE Networks of Centres of Excellence
NIH National Institutes of Health
NSERC Natural Sciences and Engineering Research Council
OECD Organisation for Economic Co-operation and Development
PA Priority Announcement
PDF Postdoctoral fellow
R&D Research and development
RCT Randomized controlled trial
S&T Science and Technology
SD Scientific Director of a CIHR Institute
SPOR Strategy on Patient-Oriented Research
SSHRC Social Sciences and Humanities Research Council
Date modified: